Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Overview

The global non-steroidal anti-inflammatory drugs (NSAIDs) market is projected to expand from USD 21.01 billion in 2023 to approximately USD 33.55 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.0% from 2024 to 2032.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5132

 Report Highlights:

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Companies

Key players in the non-steroidal anti-inflammatory drugs (NSAIDs) market include:

• Pfizer Inc.: A global leader in the pharmaceutical industry, Pfizer manufactures a variety of NSAIDs for pain and inflammation management.
• Merck & Co., Inc.: Merck offers innovative NSAID solutions and has a strong presence in the global market with several pain relief products.
• Novartis AG: A multinational pharmaceutical company, Novartis provides NSAID treatments for chronic and acute inflammatory conditions.
• GlaxoSmithKline Plc: Known for its broad portfolio, GSK is involved in the development and marketing of NSAIDs for various therapeutic applications.
• Johnson & Johnson Services Inc.: With a focus on pain management, J&J is a key player in the NSAID market, offering over-the-counter and prescription solutions.
• Bayer AG: A leading company in the healthcare sector, Bayer produces NSAIDs for the treatment of pain, fever, and inflammation.
• Dr. Reddy’s Laboratories Ltd.: Dr. Reddy’s is a prominent generic drug manufacturer that supplies affordable NSAID options globally.
• Viatris Inc.: Viatris provides a range of NSAIDs, with a focus on accessibility and affordability in the global market.
• AstraZeneca: AstraZeneca is involved in the development of NSAIDs for pain relief, particularly in the context of arthritis and other chronic conditions.
• Abbott Laboratories: Abbott offers NSAID products targeted at managing pain and inflammation, with a strong focus on both prescription and over-the-counter formulations.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/non-steroidal-anti-inflammatory-drugs-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5132

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare